Reddit Posts
Curious If Anyone Has Thoughts on IBRX (ImmunityBio)
DD (Due Diligence) IN8bio Inc. (NASDAQ: INAB) next IBRX or SLS ?
Do some trading platforms have dodgy algorithms?
$IBRX — real holder using AI for clarity, not hype. Here's why I think the fundamentals justify the run
$IBRX — real holder using AI so I don't get details wrong. 40% of the float is short and the company is genuinely great.
The r/pennystocks lounge is DYING - we need to SAVE IT
Trump might cure cancer and IBRX could moon with or without the short squeeze.
$IBRX has catalysts, 37% SI, and a creeping DTC
$IBRX DD: the class action headline looks scarier than the actual facts
$IBRX: Strengthens Balance Sheet With $100 Million Of Financing
Biotech feels broken… but that’s usually when things get interesting
$IBRX: Rising CTB, short interest over 30%
25 MATCH 2026 , BIGGEST LOSERS IN THE PRE- MARKET
I’ve been looking at this for over a year now, and now that I’ve got that year behind me, I can stop guessing and look at what actually happened. This is not financial advice. It started as speculation based on real numbers, and now there are real outcomes.
Best performing stocks year-to-date by market cap
From the IBRX community on Reddit: $IBRX - IBRX SHORT SQUEEZE ALERT: THE PRESSURE IS MOUNTING. Data driven analysis only based on the screenshots attached.
IBRX Stock: Multi-Year Expansion Roadmap Adds to Endless Run of Gains
$IBRX, Squeeze already started, OPEX today, news for Saudi Arabia this morning. Let’s squeeze the big money. Fuck Cancer
IBRX - YALL - who shorts a life saving company? What evil is that?
Risk-On Does Not Lift Everything. It Lifts the Right Beta Profiles.
$IBRX 135million shares short, 40+ % of the float. Trapped above 8$
What Softer Inflation Does to High Beta Stocks
I anyone here considering IBRX with the newly approved Anktiva aka BioShield for a possible
$IBRX (ImmunityBio) can become the next short-term rocket/long-term investment
$IBRX (ImmunityBio) can become the next short-term rocket/long-term investment
My opinion on the ongoing IBRX hype (NFA)
LAST CALL: Today is the last day you will ever see IBRX under $6.
All the AI infra stocks testing new all time highs? Its $WYFI time!
WYFI (WhiteFiber) - Low float AI infrastructure play that could squeeze to new all time highs!
WYFI (WhiteFiber) - This low float AI infrastructure play could be set to test new all time highs!
The current math for a parabolic squeeze on IBRX
$IBRX End of day report based on short activity
$IBRX End of day report based on short activity
Is $IBRX ☠️ after latest release? Selling Now or Buying the Dip?
Can't bring my cell into work, but with IBRX at this $$$ I gotta go get my cell and buy some more!
The treatment for cancer vs shorters (IBRX) BUY BUY BUY
IBRX- ignore the potentual squeeze , buy any dip
Guerilla Tagging - IBRX --- 💣💣💣💣💣💣💣💣💣💣💣💣💣💣💣💣
A Look At ImmunityBio (IBRX) Valuation After FDA Anktiva Pathway And Saudi Approvals - Result: DCF Fair value of $20.93 (UNDERVALUED)
Fuck Cramer/Cancer (Fuck CRANCER)!!! #IBRX TO THE MOON & BEYOND TOMORROW 🚀 LET'S HIT USD 15 A PIECE!
Tell me without telling me: is Cramer a sign of good Fortune? Double up on IBRX?
Lets go WSB! Time is now for the next wave! 👋
CMCT up 60% Today on News, High Risk High Reward Buy
Short Sellers Panic As Cancer Cure Drug Skyrockets In Volume
Squeeze radar today (what’s real pressure vs just talk)
Reddit Ticker Mentions JAN.22.2026 - $NFLX, $IBRX, $SPY, $ASTS, $GORO, $MSFT, $NVDA, $SLS, $VOO, $RIME
Reddit Ticker Mentions JAN.22.2026 - $NFLX, $IBRX, $SPY, $ASTS, $GORO, $MSFT, $NVDA, $SLS, $VOO, $RIME
$IBRX: Friendly Reminder: DISABLE STOCK LENDING ON YOUR ACCOUNT
IBRX to the 🌙 still got fuel in the tank
Will IBRX continue the uptrend after 12 days of gains?
ImmunityBio rally causes $492M losses for short sellers (IBRX)
How Can I Beat FOMO In This Market And Stop Buying The Peak/Ceiling?
IBRX $243M Cash + No IL15 Competitors = Moonshot
Fintel Data and Short Squeeze Update for $IBRX
How The Hell You Degenerates Pick Stocks?
IBRX: Fundamentally and Technically Strong
Dr. Pat Soon-Shiong (@DrPatrick) on X - IBRX AI-powered robots 💣💣💣💣💣
Trending IBRX, CRVS, NVAX & NUVB Stocks
IBRX saw a random Facebook reel about this company on December 11
7.50$ Surpassed Careful with Stop Losses IBRX
IBRX. A company with FDA approved drug being shorted: nonsense or has any logic?
IBRX?...note for shorters....don't short a FDA approved drug
If POTUS approved IBRX and saves 13k+ lives in the US, he will get my vote for the Nobel Peace Prize...🤴
If POTUS approved IBRX and saves 13k+ lives in the US, he will get my vote for the Nobel Peace Prize...🤴
If POTUS approved IBRX and saves 13k+ lives in the US, he will get my vote for the Nobel Peace Prize...🤴
IBRX We got headlined on Robinhood - Amazing! Overtime in 4h will be amazing! 🚀💣
IBRX We got headlined on Robinhood
Mentions
I only write up whole posts on the ones I'm willing to put myself publicly behind, but if you're just curious **(This post is not originally about these tickers, and I'm not down to go into them unless I post about them later See my NTDOY & IBRX post for that context**) I also hold the following with high expectations - PEP - amazing under 130 BA - amazing under 200 RYAAY - my favorite airline stock, cheap right now IBRX (my baby love) Nintendo (My new baby love) META (making me happy) FRMI (Actual gamble that might be a miracle) MELI (South America exposure) SLV (interest rate hedge) These are not picks I would say are guarantees at all - they're just my personal short term picks.
I guess that depends on what you call a squeeze. I don't remember seeing BWET on here as an example, but I made a decent amount of cash off of BYND, IBRX, SLS, GRPN, and LFVN. Just because they didn't AMC/GME doesn't mean you can't find a good setup/thesis.
IBRX was posted here before the big(ish) run it had
IBRX is showing signs of a ponzi scheme
IBRX is not a meme (maybe)
IBRX and SLS tmw
When will the middle east investors stop propping up IBRX
IBRX is on the move today!!! Catalyst - the company bought into another biotech, and dr. Patrick appointed to the board of directors.
GPRO holding $1.50 ($1.85 yesterday) and headed $2 + momentum is building PDSB held .30 (.65 yesterday) and with the Dr. Soon (IBRX) investment we could see a streamline Phase 3 KEEL headed to $4 then $5 good investment with 3 infrastructure contracts pending.
Small portfolio but I got in SLS at 2.2$ and IBRX at 2$. Not pennystocks but got INTC at 25$ and TSAT at 23$.
Assuming you mean HTZ.... Don't SOUN, IBRX, and ONDS look better?
SLS, IBRX, CYDY all have major catalyst.
I would look at $IBRX
100% yes…I was just looking at my tickers and realized every one of my positions AI related except 3 bios(DRTS SLS IBRX) Look at CAKE and ELF…two great non AI stocks that unfortunately I don’t own:(
Looking like a short squeeze. I've been holding a bag on that one for a couple years. It's a quality company. Considerably more revenue at the fraction of the market cap compared to IBRX.
Definitely partial. They have something that appears to work well on skin cancer when used in conjunction with Keytruda. Cancer research has a lot of promising options right now. SLS - 4 petitdes that target the WT1 receptor common in 20ish cancers and boost the immune response. IBRX - bioshield that also boosts immune response and also positive indications in a number of cancers (currently targeting bladder and lung). DRTS - delivers radiation directly to the tumor eliminating the worst side effects of chemo. There are a few others getting close as well that I can't remember off hand.
And I also wonder if there are competitors doing various forms of exactly what IBRX is doing (so technology/drug therapy concept is valid - but - another company is going to do a better job scaling it and proving it out etc). I'd still stick with IBRX but just curious if that is a major aspect that I have overlooked (presence of competitors).
Unfortunately I think you’re caught holding the bag man. Cut your losses now. I’d full send into IBRX which has short and long term potential. Others have KEEL and ASTS but I’m not as big into them. NFA
💯☝️ much of traditional finance won't touch it or the interest would be prohibitively high. PSS is assuming the risk at a significant discount which implies a discount to shareholders as well. If IBRX goes bk, PSS stands to lose the most since he's the largest shareholder. He could potentially buy it out of bankruptcy but it's still a loss.
the founder risk is real with IBRX, PSS controls like 90%+ of shares and has a history of overpromising timelines. that doesn't mean the science is bad but it does mean dilution risk is always lurking since they burn cash and have limited revenue. if you're long and convicted, fine, just keep position size small enough that a secondary offering doesn't wreck you. the international approvals are a good sign tbh, just slow to translate to actual revenue.
Long term bag holder here. Almost break even lol. It is a good company. It's somewhat interesting how it has a third the market cap of IBRX with 10x the revenue.
Thanks for the perspective. This is the only biotech stock I own, I bought the majority of my shares back when it was $3 a share. It's a company I've followed for years going back to when it was NantKwest...I otherwise don't invest in this sector. IBRX is a long term speculative bet for me. Curious if by "write options against them" you're referring to writing covered calls? If yes, I've been interested in that but not sure if it's a strategy that still works (even if you're conservative with how you do it). Additionally, when VOO, QQQ, VTSAX etc. are returning 15%-25% (give or take?) over not just a short, but intermediate to long term horizon...I also have a hard time arguing against investing in those, although I worry about whether or not those index funds, given that they track market cap weighted indices like the S&P, are truly as diversified as people think they are.
I agree with the logic. They deleted their comment for some reason, but another commenter characterized it as a highly binary play. Any investment in IBRX has to be speculation (at this time), although I am a believer that the company will scale internationally at a much quicker pace than in the US, due to a faster or more streamlined international regulatory approval process (Saudi Arabia is perhaps evidence of this), and that will drive share appreciation much more so than regulatory approval in the US (given that the FDA requires I think individually approved trials/tests for each and every type of cancer you want to treat). I think bankruptcy risk is mitigated in part by the founder, who has considerable resources, and who has in the past (going back to when it was NantKwest) put his own money into the company several times during periods when it was cash strapped (perhaps similar to what Elon Musk did with Tesla in its earlier years). I always think it's a strong signal (of commitment) when a founder puts his/her own money into their company. Overall though, I could easily fall for the "building too much conviction" trap and I wouldn't consider any of my above comments to be a particularly strong investment thesis.
Guys do you think IBRX has future or should I just take the loss?
Another episode of market bullshit: IBRX is burning through cash, yet only down 2%
Im designed to be a daytrader, scalper to my core self. I never leave my finger from hovering the sell button, unless its a high conviction play like IBRX or various ETFs.
🏛️ The FDA Approval Facts ImmunityBio's (NASDAQ: IBRX) flagship immunotherapy, **ANKTIVA® (nogapendekin alfa inbakicept-pmln)**, was officially **approved by the US FDA on April 22, 2024**. \[[1](https://immunitybio.com/immunitybio-announces-fda-approval-of-anktiva-first-in-class-il-15-receptor-agonist-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/)\] The exact approved indication is for use in combination with Bacillus Calmette-Guérin (BCG) to treat adult patients with **BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)**, with or without papillary tumors. \[[1](https://immunitybio.com/immunitybio-announces-fda-approval-of-anktiva-first-in-class-il-15-receptor-agonist-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/)\] * **Current Status (July 2026):** ImmunityBio has an active supplemental Biologics License Application (sBLA) accepted by the FDA to expand the label specifically to **papillary-only disease** without CIS. The FDA has set a PDUFA target action date for this expansion on **January 6, 2027**. \[[1](https://immunitybio.com/immunitybio-announces-fda-acceptance-of-supplemental-bla-for-anktiva-plus-bcg-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer-with-papillary-disease-pdufa-date-set-for-january-6-2027/), [2](https://finance.yahoo.com/sectors/healthcare/articles/fda-accepts-ibrxs-filing-seeking-135300166.html)\] * **Global Expansion:** This follows recent momentum where the United Arab Emirates (UAE) granted marketing authorization for ANKTIVA across both the broad bladder cancer spectrum and metastatic non-small cell lung cancer (NSCLC) Do more research
IBRX up over a UAE permit is equivalent to appointing BugLight's marketing team to wendys
IBRX stock holders too
IBRX will actually cure cancer but nobody's been ready for that one.
We all know why this was approved. Because it still serves the old gen chemo/radiation business model not really treating cancer while they proudly measure their success in "survival years" - 1-5 years being a surviving in pain ,vomiting zombie is an achievement for them before your body finally shuts down. Every zombie is worth a few hundred thousand grands of insurance money for pharma, that's why they do it. While you have companies like IBRX with proven 70%+ complete REMISSION rate, yet they're being stonewalled on every corner and getting lawsuits from under the microscope. The days of old gen are numbered, every next gen company is now researching immuno therapy approaches and they will hit like tsunami once they hit critical mass where FDA can't deny anymore or they will seek markets outside US as they already do and force FDA's acceptance because their business will fail otherwise. Companies like this are shit and are just riding on old tech.
SLS buyout rumors, IBRX russel 1000 inclusion, SRPT buyout rumors and SPACEX Nasdaq 100 inclusion
Ive been looking it, but im afraid of biotech. Can go down heavily if it doesnt work. Similar to IBRX months ago, hype and then wait
Why not IBRX instead ?
IBRX is not being shy today.
Biotech early plays. $IBRX
I’ve been digging into $IBRX and what stands out is that it’s not another pre-revenue biotech hoping for a breakthrough. They already have an approved commercial product (ANKTIVA), are ramping revenue, expanding internationally, and were recently added to the Russell 1000. Meanwhile Dr. Patrick Soon-Shiong continues to talk about expanding access globally while additional indications and studies move. … IBRX is one of the few that is already generating revenue while still having significant pipeline upside. Worth doing your own DD.
IBRX is another scam
Check out IBRX. Its legally obligated to stay between 6.50 and 8 all yearhaha
When IBRX is up, you know it's all bullshit
Who is still buying IBRX when the FDA will not release an answer until 2027. Dilution coming again before that
Why not IBRX instead ?
I'm in IBRX...another blaster pointed at cancer. "The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory." Lost my mom in '03 to cancer so I love anything that combats it. Gonna take a look at DRTS.
So then what's the play. Full porting IBRX rn
FP in IBRX for the mean time. That $12 run bound to happen again on news
I would say the market cap (1.7B) is already a bit on the high side for a typical biotech. However, it differs in a few ways from typical biotechs. It's something like 75% retail, where as most are 75% institutions. Tends to make more for pops and drops depending on the results. That said, it does have a very nice TAM and a whole bunch of indications for other cancers as well as a second drug in the pipeline. The drug has a theoretical TAM better than Keytruda, which is a 24B/yr drug. Pharma may put a much higher value than 10-12B on it. In my experience, Phase 3 is usually a pop if successful, but unless I'm playing the buyout game, I'm out before the FDA decision. That one is often priced in. If memory serves, IBRX ran up to about 2B prior to its FDA hearing. Different drug, similar story. It also has a heavy retail presence and currently sits considerably higher than 2B.
IBRX and DRTS holder here....I've been happy with my investments so far!
IBRX $15 price target...LMAO!
My SATL, IBRX, and QUCY swing last week / yesterday set up well. Buying IBRX heavily on this dip as well as OTLK.
[https://www.benzinga.com/pressreleases/26/06/b52918254/immunitybio-presents-new-clinical-and-comparative-data-across-lung-and-bladder-cancer-at-asco-2026](https://www.benzinga.com/pressreleases/26/06/b52918254/immunitybio-presents-new-clinical-and-comparative-data-across-lung-and-bladder-cancer-at-asco-2026) IBRX news
In QUCY and IBRX, why SATL? How much more could it realistically run?
QUCY, SATL, and IBRX are my swing plays I'm setting up for next week
IBRX almost back in my buying range
That is why i asked why not IBRX.. their drug Anktiva works and is expanding worldwide
Why not IBRX instead ?
SLS, IBRX, GRPN, COST. I'll gladly take it off your hands as well.
IBRX will be in the $20’s easily and DDD could be between $10-$30. I’m already collecting 25k annually in divs from F and PFE have a paid off property and renting another out for almost 3k a month that’s 75k away from being paid off. I’m thinking yeah, 2030 is pretty realistic based on my current setup but thanks for your projection!
It’s more DDD and IBRX for me I’d like to have about 10k of each so I can retire in 2030 when these absolutely are both in double digits again.
IBRX should be pumping soon
Sold my SIDU, SATL, and SPCE and re-entered IBRX at 7.22
IBRX is a steal right now. Price continue to fall after series of good news, trading well below value with solid squeeze set up
Got in 18% today, very well. first on GCTS and then a lil on IBRX
im telling u right now that these Pharma companies r super dangerous. trial makes it it will moon. trail fails this mf going to 0. along the way there is a lot of price manipulation and trickery like today. I dont trust this company and others like IBRX, DRTS for shit. Buy way OTM puts and calls on both sides because these stocks only end up on the extreme side of either.
Opinions on IBRX? It dipped but there was good news. So I bought at 7,40
Time to swing IBRX again soon
I've been in SLS for a long time. But IBRX is still a great swing stock. Easy 10-15% up and down all the time.
I had hopes, but the stock is clearly being manipulated. The chart for IBRX looks terrible now.
Sucks that IBRX did not run on fda news :(
Tempted to give up on IBRX and go for SLS. Chart looks way smoother. SEGG also holding well.
Keeping SLS or sell? Up like 86% on it and am a bit wary of it dropping and stagnating like IBRX lately
I got into DRTS at $7.50 and IBRX at $4.40. Only have about 20 shares of both, but I've been happy with the results!
In for 600 shares $2.18 avg. this and IBRX another solid one.
IBRX is my #1 and only stock now. I cleared out my entire portfolio and went all in.